Metabolic imaging in Parkinson disease

SK Meles, LK Teune, BM de Jong… - Journal of Nuclear …, 2017 - Soc Nuclear Med
This review focuses on recent human 18F-FDG PET studies in Parkinson disease. First, an
overview is given of the current analytic approaches to metabolic brain imaging data. Next …

18F-FDG PET in parkinsonism: differential diagnosis and evaluation of cognitive impairment

PT Meyer, L Frings, G Rücker… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Accurate differential diagnosis of parkinsonism is of paramount therapeutic and prognostic
importance. In addition, with the development of invasive therapies and novel disease …

[HTML][HTML] Clinical, dopaminergic, and metabolic correlations in Parkinson disease: a dual-tracer PET study

FT Liu, JJ Ge, JJ Wu, P Wu, Y Ma, CT Zuo… - Clinical nuclear …, 2018 - journals.lww.com
Purpose Neuroimaging indicators of Parkinson disease have been developed and applied
in clinical practices. Dopaminergic imaging reflects nigrostriatal dopaminergic dysfunction …

[HTML][HTML] Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease

V Berti, C Polito, P Borghammer, S Ramat… - The quarterly journal …, 2012 - ncbi.nlm.nih.gov
Aim Previous positron emission tomography (PET)[18 F] fluorodeoxyglucose ([18 F] FDG)
studies in Parkinson's disease (PD) demonstrated that moderate to late stage patients …

PET imaging in neurology: Alzheimer's and Parkinson's diseases

I Sarikaya - Nuclear Medicine Communications, 2015 - journals.lww.com
PET studies play an important role in the early detection of Alzheimer's and Parkinson's
diseases (AD and PD). Fluorine-18 fluorodeoxyglucose (18 F-FDG) PET imaging of regional …

Brain 18F-FDG PET imaging in the differential diagnosis of parkinsonism

ÜÖ Akdemir, AB Tokçaer, A Karakus… - Clinical nuclear …, 2014 - journals.lww.com
Aim The aims in this study were to evaluate the role of brain 18 F-FDG PET imaging in
differential diagnosis of parkinsonism and to correlate brain metabolism findings with …

18F-Fluorodeoxyglucose PET in the evaluation of Parkinson disease

KL Poston, D Eidelberg - PET clinics, 2010 - pet.theclinics.com
Parkinson disease (PD) is the second most common age-related neurodegenerative
disorder, affecting 1 to 2 million individuals in North America. Given that the incidence of PD …

Recent advancement and clinical implications of 18fdg-pet in parkinson's disease, atypical parkinsonisms, and other movement disorders

C Peralta, F Biafore, TS Depetris… - Current neurology and …, 2019 - Springer
Abstract Purpose of Review The molecular imaging field has been very instrumental in
identifying the multiple network interactions that compose the human brain. The cerebral …

Dynamic 18F-FPCIT PET: quantification of Parkinson disease metabolic networks and nigrostriatal dopaminergic dysfunction in a single imaging session

S Peng, C Tang, K Schindlbeck… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Previous multicenter imaging studies with 18F-FDG PET have established the presence of
motor-related and cognition-related metabolic patterns of Parkinson disease (PD), termed …

Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders

L Appel, M Jonasson, T Danfors… - Journal of Nuclear …, 2015 - Soc Nuclear Med
In idiopathic Parkinson disease and atypical parkinsonian disorders, central dopaminergic
and overall brain functional activity are altered to different degrees, causing difficulties in …